Omada Health, Inc. (OMDA)
NASDAQ: OMDA · Real-Time Price · USD
12.28
-0.67 (-5.17%)
At close: Feb 27, 2026, 4:00 PM EST
12.52
+0.24 (1.95%)
After-hours: Feb 27, 2026, 4:25 PM EST
Omada Health Stock Forecast
Stock Price Forecast
The 10 analysts that cover Omada Health stock have a consensus rating of "Buy" and an average price target of $24.8, which forecasts a 101.95% increase in the stock price over the next year. The lowest target is $17 and the highest is $29.
Price Target: $24.8 (+101.95%)
Analyst Consensus: Buy
* Price targets were last updated on Jan 22, 2026.
Analyst Ratings
The average analyst rating for Omada Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 5 | 5 | 5 | 5 |
| Hold | 1 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 9 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +128.01% | Jan 22, 2026 |
| Wells Fargo | Wells Fargo | Hold Initiates $17 | Hold | Initiates | $17 | +38.44% | Jan 9, 2026 |
| Barclays | Barclays | Buy Maintains $29 → $22 | Buy | Maintains | $29 → $22 | +79.15% | Jan 5, 2026 |
| BMO Capital | BMO Capital | Buy Initiates $27 | Buy | Initiates | $27 | +119.87% | Nov 13, 2025 |
| Barclays | Barclays | Buy Maintains $28 → $29 | Buy | Maintains | $28 → $29 | +136.16% | Nov 7, 2025 |
Financial Forecast
Revenue This Year
258.92M
from 169.80M
Increased by 52.49%
Revenue Next Year
317.64M
from 258.92M
Increased by 22.68%
EPS This Year
-0.26
from -6.10
EPS Next Year
-0.07
from -0.26
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 272.2M | 338.4M | ||
| Avg | 258.9M | 317.6M | ||
| Low | 247.9M | 293.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 60.3% | 30.7% | ||
| Avg | 52.5% | 22.7% | ||
| Low | 46.0% | 13.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 0.03 | 0.16 | ||
| Avg | -0.26 | -0.07 | ||
| Low | -0.60 | -0.31 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.